Emerging evidence has linked the gut microbiota to schizophrenia. However, the 47 functional changes in the gut microbiota and the biological role of individual bacterial 48 species in schizophrenia have not been explored systematically. Here, we 49 characterized the gut microbiota in schizophrenia using shotgun metagenomic 50 sequencing of feces from a discovery cohort of 90 drug-free patients and 81 controls, 51 as well as a validation cohort of 45 patients taking antipsychotics and 45 controls. We 52 screened 83 schizophrenia-associated bacterial species and constructed a classifier 53 comprising 26 microbial biomarkers that distinguished patients from controls with a 54 0.896 area under the receiver operating characteristics curve (AUC) in the discovery 55 cohort and 0.765 AUC in the validation cohort. Our analysis of fecal metagenomes 56 revealed that schizophrenia-associated gut-brain modules included short-chain fatty 57 acids synthesis, tryptophan metabolism, and synthesis/degradation of 58 neurotransmitters including glutamate, γ-aminobutyric acid, and nitric oxide. The 59 schizophrenia-enriched gut bacterial species include several oral cavity-resident 60 microbes, such as Streptococcus vestibularis. We transplanted Streptococcus 61 vestibularis into the gut of the mice with antibiotic-induced microbiota depletion to 62 explore its functional role. We observed that this microbe transiently inhabited the 63 mouse gut and this was followed by hyperactivity and deficit in social behaviors, 64 accompanied with altered neurotransmitter levels in peripheral tissues. In conclusion, 65 our study identified 26 schizophrenia-associated bacterial species representing 66 potential microbial targets for future treatment, as well as gut-brain modules, some of 67 which may give rise to new microbial metabolites involved in the development of 68 schizophrenia. 69 70 Schizophrenia is a severe psychiatric disorder associated with hallucinations, 71 delusions, and thought disorders perturbing perception and social interaction 1 . The 72 etiology of schizophrenia is not elucidated, but assumed to be multifactorial involving 73 genetic and environmental factors. Abnormalities of neurotransmitter systems have 74 been extensively studied especially focusing on aberration of signaling involving 75 dopamine, glutamate, and γ-aminobutyric acid (GABA) 2-4 . Increasing evidence 76 indicates that schizophrenia may be a systemic disorder with neuropsychiatric 77 conditions in addition to psychosis 5 . Furthermore, the importance of inflammation 6 78 and the involvement of the gastrointestinal system 7 in schizophrenia have received 79 attention. 80 The gut microbiota is reported to play an important role in neurogenerative 81 processes, and perturbation of the microbiota and microbial products have been 82 demonstrated to affect behavior 8-10 . Changes in the gut microbiota have been 83 associated with neurological 11 and neurodevelopmental disorders 12,13 , including 84 schizophrenia 14 . It was recently reported that fecal transfer of the gut microbiota from 85 patients with schizophrenia induces schizophrenia-associated behaviors in germ-free 86 recipient mice accompanied with altered levels of glutamate, glutamine, and GABA in 87 the hippocampus 13 . However, the identity and functionality of the specific bacteria 88 responsible for mediating changes in the behavior of recipient mice are unknown 15,16 . 89 Thus, the composition and functional capacity of the gut microbiota in relation to 90 schizophrenia need to be systematically examined. Taxa and functional profiling of 91 the microbiota composition is a premise for functional understanding of the gut 92 microbiota 17 . Previous studies were based on 16S rRNA gene amplicon sequencing 93 of relatively small cohorts 14,18-20 and hence failed to provide detailed functional 94 profiling of the gut microbiota in schizophrenia. Metagenomic shotgun sequencing 95 5 combined with bioinformatics tools enables better characterization of the 96 microbiota 21 , including a more accurate prediction of biological features of the 97 microbes and their impacts on host physiology 22 . 98 Here, we carried out a metagenome-wide association study (MWAS) using 99 171 samples (90 cases and 81 controls) and validated the results with an additional 90 100 samples (45 cases and 45 controls). The functional changes within the schizophrenia 101 gut microbiota were determined using pathway/module analysis based on the Kyoto 102 Encyclopedia of Genes and Genomes (KEGG) and a recently developed gut-brain 103 module (GBM) analysis of fecal metagenomes 23 . The functional roles of one 104 particular schizophrenia-enriched gut bacterial species, Streptococcus vestibularis, 105
Introduction
mOTUs (Spearman's correlation coefficient < -0.3 or >0.3, P < 0.05). The mOTU 137 species from the genera Streptococcus and Veillonella showed positive cross-138 correlations. Moreover, the majority of the species in these two clusters of correlated 139 mOTUs originated from the oral cavity, suggesting that orally resident bacteria in a 140 synergistic manner may colonize the gut in schizophrenic patients ( Fig. 1 and 141 Supplementary Table 5a ). 142 Functional modules and pathways enriched in the gut microbiota of patients relative 143 to controls were analyzed using the KEGG database (Supplementary Table 6 ). The 144 relative enrichment of 579 KEGG modules and 323 KEGG pathways varied 145 significantly between the two groups. Schizophrenia-depleted microbial functional 146 modules included pectin degradation, lipopolysaccharide biosynthesis, autoinducer-2 147 (AI-2) transport system, glutamate/aspartate transport system, beta-carotene 148 biosynthesis, whereas schizophrenia-enriched functional modules included 149 methanogenesis, the gamma-aminobutyrate (GABA) shunt, and transport system of 150 manganese, zinc, and iron ( Supplementary Table 6 ).
151
Neuroactive potential of schizophrenia-related bacterial species 152 We next compared the altered microbial neuroactive potential of the gut microbiota 153 of schizophrenic patients with the controls at the species level using the method 154 reported by Valles-Colomer et al. 23 . We mapped the metagenomic data of the 171 155 samples to a genome database including the 42 microbial species that were detected 156 based on the 83 schizophrenia-associated mOTUs using PanPhlAn 26 and calculated 157 the prevalence of species-level microbes. We then determined whether the abundance 158 of 56 previously reported gut-brain modules (GBMs) 23 , present in each microbial 159 species, varied significantly between schizophrenic patients and controls. The GBM 160 set of each microbial species was obtained by cross-checking GBM-related genes and 161 the species gene repertoires (Supplementary Table 7a ). The frequency of the 162 occurrence of each GBM within each species was compared between patients and 163 controls using a Chi-squared test ( Supplementary Table 7b ). GBMs included short-chain fatty acid synthesis (acetate, propionate, butyrate, and 165 isovaleric acid), tryptophan metabolism, and the synthesis of several 166 neurotransmitters, such as glutamate, GABA, and nitric oxide (Fig. 2) . 167 We chose to validate the presence of the GBM associated with tryptophan 168 metabolism in schizophrenia, as tryptophan metabolism also is modulated by the gut 169 microbiota and implicated in schizophrenia pathogenesis 27, 28 . Hence, serum 170 tryptophan metabolites were measured in patients and controls and correlated with the 171 presence of tryptophan modules in the gut microbiota. In agreement with the higher 172 abundance of tryptophan metabolisms related GBMs, we observed lower serum 173 tryptophan levels and higher kynurenic acid (KYNA) levels in schizophrenic 174 patients( Supplementary Fig. 2a, c) . Moreover, serum tryptophan levels were 175 negatively correlated with the abundances of 38 bacterial species enriched in 176 schizophrenic patients and positively correlated with six bacterial species enriched in 177 controls ( Supplementary Fig. 2d ). Similarly, serum KYNA levels were positively 178 correlated with 10 schizophrenia-enriched bacterial species and negatively correlated 179 with 3 control-enriched bacterial species ( Supplementary Fig. 2d ). Thus, an altered 180 gut microbiota may be associated with changes in serum levels of tryptophan and 181 KYNA in schizophrenia.
182
Microbial species-based biomarkers for schizophrenia 183 To identify novel gut bacterial biomarkers and evaluate their diagnostic values for 184 schizophrenia, we first constructed a set of random forest disease classifiers based on 185 gut mOTUs. We performed a five-fold cross-validation procedure ten times on 90 186 patients and 81 controls. Twenty six gut mOTUs reached the lowest classifier error in 187 the random forest cross validation, and the ROC AUC score of the model was 0.896 188 (Fig 3a, b ). This microbial based classifier was not significantly influenced by age, 189 gender, BMI, and diet style ( Supplementary Table 8 ). This discriminatory model was improved greatly along with treatment ( Supplementary Fig. 3 ). However, only 204 approximately half of the microbial biomarkers returned to the levels in controls after 205 treatment ( Fig. 3d ). As the sample size of the follow-up patients was smaller, the Fig. 3 and Supplementary Fig. 2 C57BL/6 mice after antibiotics-based microbiota depletion ( Supplementary Fig. 4 ).
232
Another strain of streptococcus, S. thermophilus ST12, which is widely present in the the behavioral tests as compared to the control mice ( Supplementary Fig. 5 ).
239
Compared to control mice gavaged with buffer or with S. thermophilus, the S. continued their hyperlocomotion after the 10-minute habituation period and showed 244 no obvious decline in locomotion activity after a period of 30-minutes ( Fig. 4c ). In the 245 three-chamber social test, the S. vestibularis mice displayed obvious deficits in 246 sociability and social novelty, as they were much less sociable and avoided social 247 novelty ( Fig. 4e -g). However, in Barnes maze, elevated plus maze, and tail suspension 248 test, the mice transplanted with S. vestibularis displayed spatial memory function, 249 depressive state, and anxiety levels similar to either saline or S. thermophilus-treated 250 mice ( Supplementary Fig. 6 ). There were no significant changes in body weight, 
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We then compared the transcriptome and neurotransmitter levels between S. 255 vestibularis-treated and saline-treated mice in their peripheral tissues and brain. S. 256 vestibularis treated mice had significantly lower levels of dopamine in serum,
257
intestinal contents, and colonic tissue, as well as decreased GABA levels in the 258 intestinal contents immediately after the transplantation, but these effects disappeared 259 after 10 days of post-transplantation ( Supplementary Fig. 8b , e, h, and f). Intestinal 260 contents of S. vestibularis-treated mice showed increased levels of 5-HT throughout 261 the behavioral tests ( Supplementary Fig. 8d ). S. vestibularis transplantation did not 
